266
Views
1
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Association between adherence to statin therapy and low-density lipoprotein cholesterol (LDL-c) response in first-time users of standard-dose and low-dose statins: the PharmLines initiative

, , , , ORCID Icon &
Pages 1-6 | Received 13 Sep 2021, Accepted 19 Sep 2021, Published online: 19 Oct 2021

References

  • Chou R, Dana T, Blazina I, et al. Statins for prevention of cardiovascular disease in adults. JAMA. 2016;316(19):2008–2024.
  • Stone NJ. Statins in secondary prevention: intensity matters. J Am Coll Cardiol. 2017;69(22):2707–2709.
  • Nederlands Huisartsen Genootschap. Multidisciplinaire richtlijn cardiovasculair risicomanagement (herziening 2011); 2011.
  • Piepoli MF, Hoes AW, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381.
  • Meerding WJ, Webb K, Sturkenboom MC, et al. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice. Pharmacotherapy. 2012;32(7):631–641.
  • Vries FD, Voorham J, Hak E, et al. Prescribing patterns, adherence and LDL-cholesterol response of type 2 diabetes patients initiating statin on low-dose versus standard-dose treatment: a descriptive study. Int J Clin Pract. 2016;70(6):482–492.
  • Lewey J, Shrank WH, Bowry ADK, et al. Gender and racial disparities in adherence to statin therapy: a meta-analysis. Am Heart J. 2013;165(5):665–678.e1.
  • van der Ende MY, Hartman MHT, Hagemeijer Y, et al. The lifelines cohort study: prevalence and treatment of cardiovascular disease and risk factors. Int J Cardiol. 2017;228:495–500.
  • Visser ST, Schuiling-Veninga CC, Bos JH, et al. The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges. Expert Rev Pharmacoecon Outcomes Res. 2013;13(3):285–292.
  • Scholtens S, Smidt N, Swertz MA, et al. Cohort profile: lifeLines, a three-generation cohort study and biobank. Int J Epidemiol. 2015;44(4):1172–1180.
  • Sediq R, van der Schans J, Dotinga A, et al. Concordance assessment of self-reported medication use in the Netherlands three-generation lifelines cohort study with the pharmacy database IADB.nl: the PharmLines Initiative. Clin Epidemiol. 2018;10:981–989.
  • Stolk RP, Rosmalen JGM, Postma DS, et al. Universal risk factors for multifactorial diseases: lifelines: a three-generation population-based study. Eur J Epidemiol. 2008;23(1):67–74.
  • Robert WC. The rule of 5 and the rule of 7 in lipid lowering by statin drugs. Am J Cardiol. 1997;80:106–107.
  • Ferrieres J, de Ferrari GM, Hermans MP, et al. Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: results from DYSIS II Europe. Eur J Prev Cardiolog. 2018;25(18):1966–1976.
  • Reiner Ž, Tedeschi-Reiner E. Prevalence and types of persistent dyslipidemia in patients treated with statins. Croat Med J. 2013;54(4):339–345.
  • Nederlands Huisartsen Genootschap. Cardiovasculair risicomanagement (M84); 2019.
  • Palmer MK, Nicholls SJ, Lundman P, et al. Achievement of LDL-c goals depends on baseline LDL-c and choice and dose of statin: an analysis from the VOYAGER database. Eur J Prev Cardiolog. 2013;20(6):1080–1087.
  • Oni-Orisan A, Hoffmann TJ, Ranatunga D, et al. Characterization of statin low-density lipoprotein cholesterol dose-response using electronic health records in a large population-based cohort. Circ Genom Precis Med. 2018;11:e002043.
  • Pavanello C, Mombelli G. Considering gender in prescribing statins: what do physicians need to know? Clin Lipid. 2015;10(6):499–512.
  • Alfian SD, Worawutputtapong P, Schuiling-Veninga CCM, et al. Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands. Curr Med Res Opin. 2018;34(6):1013–1019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.